Cleared Traditional

K182360 - Teleport Microcatheter

K182360 is the FDA 510(k) clearance for Teleport Microcatheter by Orbusneich Medical Trading, Inc.. It is a Class 2 Cardiovascular device (product code DQY) cleared through the Traditional 510(k) pathway after a 71-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Nov 2018
Decision
71d
Days
Class 2
Risk

K182360 is an FDA 510(k) clearance for the Teleport Microcatheter. Classified as Catheter, Percutaneous (product code DQY), Class II - Special Controls.

Submitted by Orbusneich Medical Trading, Inc. (Fort Lauderdale, US). The FDA issued a Cleared decision on November 9, 2018 after a review of 71 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1250 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Orbusneich Medical Trading, Inc. devices

Submission Details

510(k) Number K182360 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received August 30, 2018
Decision Date November 09, 2018
Days to Decision 71 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
54d faster than avg
Panel avg: 125d · This submission: 71d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code DQY Catheter, Percutaneous
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1250
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQY Catheter, Percutaneous

All 573
Devices cleared under the same product code (DQY) and FDA review panel - the closest regulatory comparables to K182360.
Route 92 Medical Delivery Catheter
K182512 · Route 92 Medical, Inc. · Dec 2018
Tractus Crossing Support Catheter
K180889 · Tractus Vascular, LLC · Dec 2018
React 71 Catheter
K182097 · Micro Therapeutics, Inc. d/b/a ev3 Neurovascular · Nov 2018
GORE Tri-Lumen Catheter
K180919 · W. L. Gore and Associates, Inc. · Oct 2018
The ARTERIAL WAND Safety Introducer with Arterial Catheter made of ChronoFlex C with BioGUARD Technology
K181563 · Access Scientific, LLC · Sep 2018
SelectFlex 072 Neurovascular Access System
K181000 · Q'Apel · Sep 2018